NO178375C - Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonister - Google Patents
Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonisterInfo
- Publication number
- NO178375C NO178375C NO904061A NO904061A NO178375C NO 178375 C NO178375 C NO 178375C NO 904061 A NO904061 A NO 904061A NO 904061 A NO904061 A NO 904061A NO 178375 C NO178375 C NO 178375C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- nmda antagonists
- analogous process
- active nmda
- Prior art date
Links
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40947889A | 1989-09-19 | 1989-09-19 | |
| US50833390A | 1990-04-11 | 1990-04-11 | |
| US07/553,431 US5095009A (en) | 1990-04-11 | 1990-07-20 | NMDA antagonists |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO904061D0 NO904061D0 (no) | 1990-09-18 |
| NO904061L NO904061L (no) | 1991-03-20 |
| NO178375B NO178375B (no) | 1995-12-04 |
| NO178375C true NO178375C (no) | 1996-03-13 |
Family
ID=27410806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO904061A NO178375C (no) | 1989-09-19 | 1990-09-18 | Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonister |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0418863B1 (ko) |
| JP (1) | JP2934295B2 (ko) |
| KR (2) | KR100191116B1 (ko) |
| CN (1) | CN1027694C (ko) |
| AR (2) | AR247889A1 (ko) |
| AT (1) | ATE116653T1 (ko) |
| AU (1) | AU632362B2 (ko) |
| CA (1) | CA2025326C (ko) |
| DE (1) | DE69015745T2 (ko) |
| DK (1) | DK0418863T3 (ko) |
| ES (1) | ES2069644T3 (ko) |
| FI (1) | FI102613B1 (ko) |
| GR (1) | GR3015656T3 (ko) |
| HU (1) | HU207523B (ko) |
| IE (1) | IE65118B1 (ko) |
| IL (1) | IL95718A (ko) |
| MX (1) | MX9203696A (ko) |
| NO (1) | NO178375C (ko) |
| NZ (1) | NZ235322A (ko) |
| PT (1) | PT95344B (ko) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5554773A (en) * | 1991-11-15 | 1996-09-10 | Merrell Pharmaceuticals Inc. | N-trityl protected aspartic acid derivatives for the preparation of phosphonate NMDA antagonists |
| ES2087555T3 (es) * | 1991-11-15 | 1996-07-16 | Merrell Pharma Inc | Derivados de acido n-tritilo aspartico utilizados para la preparacion de antagonistas de fosfonato nmda. |
| GB9325368D0 (en) * | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
| EP0684238A3 (en) * | 1994-04-27 | 1997-01-15 | Hoffmann La Roche | Process for the preparation of dicarboxamides. |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3970684A (en) * | 1973-07-06 | 1976-07-20 | Syntex (U.S.A.) Inc. | Polyunsaturated prostaglandin derivatives |
| CA1248531A (en) * | 1984-04-17 | 1989-01-10 | Jeffrey C. Watkins | 4-substituted piperazine-2-carboxylic acids |
-
1990
- 1990-09-13 CA CA002025326A patent/CA2025326C/en not_active Expired - Fee Related
- 1990-09-13 AU AU62474/90A patent/AU632362B2/en not_active Ceased
- 1990-09-14 NZ NZ235322A patent/NZ235322A/en unknown
- 1990-09-17 IL IL95718A patent/IL95718A/en not_active IP Right Cessation
- 1990-09-18 FI FI904588A patent/FI102613B1/fi not_active IP Right Cessation
- 1990-09-18 IE IE338090A patent/IE65118B1/en not_active IP Right Cessation
- 1990-09-18 KR KR1019900014729A patent/KR100191116B1/ko not_active IP Right Cessation
- 1990-09-18 NO NO904061A patent/NO178375C/no not_active IP Right Cessation
- 1990-09-18 HU HU905945A patent/HU207523B/hu not_active IP Right Cessation
- 1990-09-18 PT PT95344A patent/PT95344B/pt not_active IP Right Cessation
- 1990-09-19 ES ES90118033T patent/ES2069644T3/es not_active Expired - Lifetime
- 1990-09-19 CN CN90104580A patent/CN1027694C/zh not_active Expired - Fee Related
- 1990-09-19 AT AT90118033T patent/ATE116653T1/de not_active IP Right Cessation
- 1990-09-19 DK DK90118033.1T patent/DK0418863T3/da active
- 1990-09-19 DE DE69015745T patent/DE69015745T2/de not_active Expired - Fee Related
- 1990-09-19 EP EP90118033A patent/EP0418863B1/en not_active Expired - Lifetime
- 1990-09-19 JP JP2247635A patent/JP2934295B2/ja not_active Expired - Lifetime
- 1990-09-19 AR AR90317901A patent/AR247889A1/es active
-
1991
- 1991-01-25 AR AR91318918A patent/AR248028A1/es active
-
1992
- 1992-06-29 MX MX9203696A patent/MX9203696A/es unknown
-
1995
- 1995-04-03 GR GR950400800T patent/GR3015656T3/el unknown
-
1998
- 1998-09-29 KR KR1019980040434A patent/KR100196265B1/ko not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO180586C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| FI96861C (fi) | Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi | |
| NO179639C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser | |
| NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
| FI890282A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
| NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
| NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
| NO175100C (no) | Analogifremgangsmåte til fremstilling av terapeutisk aktive 4(3H)-pteridinoner | |
| NO900032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. | |
| NO176273C (no) | Analogifremgangsmåte for fremstilling av aktive substituerte benzamider | |
| NO173334C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive alkylaminoalkylenderivater 2H-1-benzopyraner | |
| NO177096C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner | |
| FI880467A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi | |
| NO173503C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner | |
| NO173784C (no) | Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater | |
| NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
| NO174892C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte dihydropyrrolizinforbindelser | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| NO174774C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner | |
| FI903077A0 (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia | |
| FI100799B (fi) | Menetelmä terapeuttisesti aktiivisten tetraliinijohdannaisten valmista miseksi | |
| NO178375C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonister | |
| NO175780C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte dibenzofuraner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN MARCH 2001 |